Skip to content
akaturk Academic measurement
Search

Article detail · 2024 · article

Effectiveness and Safety of Initiation and Titration of Insulin Glargine 300 U/mL in Insulin-Naive Patients with Type 2 Diabetes Mellitus Uncontrolled on Oral Antidiabetic Drug Treatment in Turkey: The EASE Study

Journal Endocrinol Res Pract The ISSN points to another catalog journal; the name is from the YÖKSİS record.
ISSN2822-6135
YÖKSİS OpenAlex Open access · diamond TR Index
Year2024
Citations2OpenAlex
Percentile%64.8
FWCI0.511.00 = world average
Scopus (SJR)Q4
WoS (JCR)Q4

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueEndocrinol Res Pract
  • Catalog match (ISSN)Endocrinology Research and Practice
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

Objective: The aim of the study was to evaluate the effectiveness and safety of insulin glargine 300 U/ mL (Gla-300) in insulin-naive patients with type 2 diabetes mellitus (T2DM) inadequately controlled on oral antidiabetic drug (OADs) treatment in Turkey. Methods: One hundred eight patients from 20 centers enrolled in the study. Starting from baseline, Gla-300 was self-administered subcutaneously and once daily in the evening. The primary outcome was the mean change in glycated hemoglobin A1c (HbA1c) from baseline to week 24. Results: The mean (±SD) Hb1Ac level of 9.4% (±0.8) at baseline decreased to 7.5% (±0.9) at week 12 (P < .1) and to 7.3% (±0.9) at week 24 (P < .1). Although none of the patients were within the target Hb1Ac level of ≤7% at baseline, the percentage of patients who achieved the target Hb1Ac level was 30.4% at week 12 and increased to 42.9% at week 24. Gla-300 treatment achieved the Hb1Ac target in 21 (19.4%) patients without experiencing a hypoglycemic event and in 27 (25.0%) patients who experienced at least one hypoglycemic event. For each self-monitoring blood glucose time point, significant improvements were observed as compared to baseline (P < .001). Statistically significant improvement (P < .001) was seen in the treatment satisfaction questionnaire – status version scores between baseline and week 24. Conclusion: This study indicated that Gla-300 is effective to provide a successful glycemic control with low risk of hypoglycemia added to OADs in insulin-naive patients with T2DM, and it has the potential to improve the quality of life of patients. Cite this article as: Çetinarslan B, Çetinkalp S, Kaya A, et al. Effectiveness and safety of initiation and titration of insulin glargine 300 U/mL in insulin-naive patients with type 2 diabetes mellitus uncontrolled on oral antidiabetic drug treatment in Turkey: The EASE study. Endocrinol Res Pract. 2024;28(1):4-11.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

2citationsOpenAlex · cited_by_count (cache / database)

Authors

20
  1. Berrin Çetinarslan 1
  2. ŞEVKİ ÇETİNKALP EGE ÜNİVERSİTESİ 2
  3. AHMET KAYA 3
  4. CANAN ERSOY 4
  5. MEDİNE NUR KEBAPÇI 5
  6. ABDURRAHMAN ÇÖMLEKÇİ 6
  7. NESLİHAN BAŞÇIL TÜTÜNCÜ 7
  8. OĞUZHAN DEYNELİ 8
  9. AYTEKİN OĞUZ 9
  10. Hasan İlkova 10
  11. MEHMET TEMEL YILMAZ 11
  12. ZELİHA HEKİMSOY MANİSA CELÂL BAYAR ÜNİVERSİTESİ 12
  13. MUSTAFA ÜNÜBOL 13
  14. MUSTAFA KEMAL BALCI 14
  15. AYŞEGÜL ATMACA 15
  16. SELÇUK DAĞDELEN 16
  17. İLHAN YETKİN 17
  18. SERDAR GÜLER 18
  19. Göktürk Ötünç 19
  20. leyla özhan 20